Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of the Endovascular Infusion of Bone Marrow Derived Mononuclear Cells in Patients With Focal Segmental Glomerulosclerosis

NCT02693366 is registered in ClinicalTrials.gov with Universidade Federal do Rio de Janeiro as lead sponsor.

NCT NCT02693366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02693366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of the Endovascular Infusion of Bone Marrow Derived Mononuclear Cells in Patients With Focal Segmental Glomerulosclerosis
Lead sponsor
Universidade Federal do Rio de Janeiro
Phase
Phase 1
Overall status
Completed
Start date
June 25, 2015
Completion date
May 16, 2018
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, focal segmental glomerulosclerosis